ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
DiagnosesAcute Inflammatory Demyelinating Polyneuropathy

Acute Inflammatory Demyelinating Polyneuropathy

ICD-10 Coding for Acute Inflammatory Demyelinating Polyneuropathy(G61.0)

PRIMARY SPECIALTYNeurology
COMPLEXITYHigh
LAST UPDATED09/15/2025
Sam Tuffun, PT, DPT
Physical Therapist | Medical Coding & Billing Contributor

Diagnosis Overview

What is Acute Inflammatory Demyelinating Polyneuropathy?
Essential facts and insights about Acute Inflammatory Demyelinating Polyneuropathy

Key Clinical Considerations:

  • Rapid onset of weakness, typically starting in the legs and ascending to the upper body.
  • Presence of areflexia or hyporeflexia during physical examination.
  • Elevated protein levels in cerebrospinal fluid (CSF) with normal white blood cell count (albuminocytologic dissociation).
  • Electromyography (EMG) showing demyelination patterns.
  • Severity can be assessed using the Medical Research Council (MRC) scale for muscle strength.

Clinical Information

Clinical Criteria & Documentation Requirements

  • Complete medical history including onset and progression of symptoms.
  • Specific terminology such as 'acute', 'inflammatory', 'demyelinating', and 'polyneuropathy' must be documented.
  • Examples include: 'Patient presents with acute weakness and sensory loss consistent with GBS.'
  • Documentation must demonstrate medical necessity for diagnostic tests and treatments.
  • Quality measures may include documentation of symptom duration and treatment response.

Coding Guidelines

Usage Guidelines & Examples

  • Use G61.0 for patients with classic symptoms of acute inflammatory demyelinating polyneuropathy.
  • Do NOT use this code for chronic inflammatory demyelinating polyneuropathy (CIDP) or other neuropathies.
  • Compare with G61.1 (CIDP) and G62.9 (polyneuropathy, unspecified) for differential diagnosis.
  • Common errors include misclassifying CIDP as G61.0; ensure symptom duration is considered.
  • In complex cases, consider additional codes for co-existing conditions or complications.

Code Exclusions

Important Exclusions

  • Excludes conditions like CIDP, diabetic neuropathy, and hereditary neuropathies.
  • Alternative codes for excluded conditions include G61.1 for CIDP.
  • Conditions are excluded due to differing pathophysiology and treatment approaches.
  • Common mistakes include using G61.0 for chronic cases; ensure accurate symptom timeline.
  • Related but distinct conditions include Miller Fisher syndrome and other variants of GBS.

Related ICD-10 Codes

Primary Codes
G61.0
Acute inflammatory demyelinating polyneuropathy
G61.1
Chronic inflammatory demyelinating polyneuropathy
Ancillary Codes
J96.0
Differential Codes
G61.81

Related CPT Codes

CPT codes will be available in a future update.

Specialty Focus

Primary Specialty

Neurology

Specialty Applications

  • Applies to patients with acute onset of neurological symptoms.
  • Patient populations include all ages, with a higher incidence in young adults.
  • Clinical settings include inpatient care for acute management and outpatient follow-up.
  • Specialty-specific applications are primarily in neurology and rehabilitation.
  • Treatment contexts include acute care settings and long-term rehabilitation.

Coding Complexity

High Complexity

This diagnosis requires careful attention to:

  • Comprehensive clinical documentation
  • Accurate code selection based on clinical criteria
  • Proper exclusion considerations
  • Specialty-specific coding guidelines

Documentation

Documentation Templates

Template 1

Template: 'Patient diagnosed with acute inflammatory demyelinating polyneuropathy based on clinical findings of weakness and areflexia.'

Template 2

Template: 'Clinical presentation consistent with G61.0 including rapid onset of limb weakness and sensory changes.'

Template 3

Template: 'Diagnostic criteria for G61.0 met as evidenced by elevated protein in CSF and EMG findings.'

Template 4

Template: 'Treatment plan initiated for G61.0 with intravenous immunoglobulin therapy.'

Template 5

Template: 'Follow-up care for G61.0 including monitoring of muscle strength and respiratory function.'

Billing Information

Billing Considerations

  • Ensure proper documentation for billing
  • Verify code specificity requirements
  • Check for any additional codes needed
  • Review payer-specific guidelines

Common Issues

  • Insufficient clinical documentation
  • Incorrect code selection
  • Missing supporting diagnoses
  • Timing and frequency documentation

Frequently Asked Questions

What documentation is required for this diagnosis?

Detailed documentation of clinical findings, symptom onset, and diagnostic test results.

How does this differ from similar diagnoses?

G61.0 is characterized by acute onset and specific clinical features, unlike CIDP which is chronic.

What are common billing considerations?

Ensure documentation supports medical necessity and aligns with payer guidelines for acute care.

What procedures are typically associated?

Related CPT codes may include nerve conduction studies and lumbar puncture for CSF analysis.

Are there any quality reporting implications?

Quality measures may include tracking treatment outcomes and patient follow-up care.